Literature DB >> 23702360

Anal fistula with foot extension-Treated by kshara sutra (medicated seton) therapy: A rare case report.

P Bhat Ramesh1.   

Abstract

INTRODUCTION: An 'anal' fistula is a track which communicates anal canal or rectum and usually is in continuity with one or more external openings. Distant communication from rectum is rare. It is a challenging disease because of its recurrence especially, with high level and distant communications. Ksharasutra (medicated seton) therapy is being practiced in India with high success rate (recurrence of 3.33%) in the management of complicated anal fistula. PRESENTATION OF CASE: A 56 year old man presented with recurrent boils in the left lower limb at different places from thigh to foot. He underwent repeated incision and drainage at different hospitals. Examination revealed sinus with discharge and multiple scars on left lower limb from thigh up to foot. Suspecting anal fistula, MRI was advised which revealed a long cutaneous fistula from rectum to left lower limb. Patient was treated with Ksharasutra therapy. Within 6 months of treatment whole tract was healed completely. DISCUSSION: Sushrutha (500BC) was the first to explain the role of surgical excision and use of kshara sutra for the management of anal fistula. Ksharasutra therapy showed least recurrence. Fistula from rectum to foot is of extremely rare variety. Surgical treatment of anal fistula requires hospitalization, regular post-operative care, is associated with a significant risk of recurrence (0.7-26.5%) and a high risk of impaired continence (5-40%).
CONCLUSION: Rectal fistula communicating till foot may be a very rare presentation in proctology practice. Kshara sutra treatment was useful in treating this condition, with minimal surgical intervention with no recurrence.
Copyright © 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2013        PMID: 23702360      PMCID: PMC3679440          DOI: 10.1016/j.ijscr.2013.04.004

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  6 in total

1.  Successful non-operative treatment of high rectal fistula.

Authors:  P J Deshpande; K R Sharma
Journal:  Am J Proctol       Date:  1976-02

2.  Anal fistula surgery. Factors associated with recurrence and incontinence.

Authors:  J Garcia-Aguilar; C Belmonte; W D Wong; S M Goldberg; R D Madoff
Journal:  Dis Colon Rectum       Date:  1996-07       Impact factor: 4.585

3.  Results of treatment of fistula-in-ano.

Authors:  C A Vasilevsky; P H Gordon
Journal:  Dis Colon Rectum       Date:  1985-04       Impact factor: 4.585

4.  Multicentric randomized controlled clinical trial of Kshaarasootra (Ayurvedic medicated thread) in the management of fistula-in-ano. Indian Council of Medical Research.

Authors: 
Journal:  Indian J Med Res       Date:  1991-06       Impact factor: 2.375

5.  Fistula-in-ano. Clinical features and long-term results of surgery in 199 adults.

Authors:  P Sainio; A Husa
Journal:  Acta Chir Scand       Date:  1985

6.  Fistula-in-ano, an investigation of human foetal anal ducts and intramuscular glands and a clinical study of 150 patients.

Authors:  H G Lilius
Journal:  Acta Chir Scand Suppl       Date:  1968
  6 in total
  3 in total

1.  The Easiest Way to Insert Ksharsutra with the Help of an Infant Feeding Tube Instead of a Metallic Probe.

Authors:  Anil Kumar; Manoj Kumar; Abhijeet Kumar Jha; Bindey Kumar; Rekha Kumari
Journal:  Indian J Surg       Date:  2017-06-21       Impact factor: 0.656

2.  Efficacy of Guggulu and Shallaki based Ksharasutra with Triphala Guggulu orally in the management of Bhagandara w.s.r. to fistula-in-ano: A open labelled randomized comparative clinical study.

Authors:  Aditya Nema; Sanjay Kumar Gupta; Tukaram Dudhamal; Vyasdeva Mahanta
Journal:  Ayu       Date:  2022-06-03

3.  Transrectal Ultra Sonography based evidence of Ksharasutra therapy for Fistula-in-ano - A case series.

Authors:  Aditya Nema; Sanjay Kumar Gupta; Tukaram S Dudhamal; Vyasadeva Mahanta
Journal:  J Ayurveda Integr Med       Date:  2017-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.